Zobrazeno 1 - 10
of 272
pro vyhledávání: '"Anderluzzi G"'
Autor:
Franzé S; Department of Pharmaceutical Sciences, University of Milan, via Mangiagalli 25, 20133, Milan, Italy. Electronic address: silvia.franze@unimi.it., Rama F; Department of Pharmaceutical Sciences, University of Milan, via Mangiagalli 25, 20133, Milan, Italy., Scarpa E; Department of Pharmaceutical Sciences, University of Milan, via Mangiagalli 25, 20133, Milan, Italy., Violatto MB; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy., Peqini K; Department of Pharmaceutical Sciences, University of Milan, via Mangiagalli 25, 20133, Milan, Italy., Gennari CGM; Department of Pharmaceutical Sciences, University of Milan, via Mangiagalli 25, 20133, Milan, Italy., Anderluzzi G; Department of Pharmaceutical Sciences, University of Milan, via Mangiagalli 25, 20133, Milan, Italy., Camastra R; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy., Salmaso A; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy., Moscatiello G; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy., Pellegrino S; Department of Pharmaceutical Sciences, University of Milan, via Mangiagalli 25, 20133, Milan, Italy., Rizzello L; Department of Pharmaceutical Sciences, University of Milan, via Mangiagalli 25, 20133, Milan, Italy., Bigini P; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy., Cilurzo F; Department of Pharmaceutical Sciences, University of Milan, via Mangiagalli 25, 20133, Milan, Italy.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2024 Aug 15; Vol. 661, pp. 124413. Date of Electronic Publication: 2024 Jul 01.
Autor:
Anderluzzi G; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy., Ghitti M; Biomolecular NMR Group, Division of Genetics and Cell Biology, IRCCS Ospedale San Raffaele Scientific Institute, Milan, Italy., Gasparri AM; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy., Taiè G; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy., Sacchi A; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy., Gori A; Istituto di Scienze e Tecnologie Chimiche, C.N.R., Milan, Italy., Andolfo A; ProMeFa, Proteomics and Metabolomics Facility, Center for Omics Sciences, IRCCS Ospedale San Raffaele Scientific Institute, Milan, Italy., Pozzi F; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy., Musco G; Biomolecular NMR Group, Division of Genetics and Cell Biology, IRCCS Ospedale San Raffaele Scientific Institute, Milan, Italy., Curnis F; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy. curnis.flavio@hsr.it., Corti A; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy. corti.angelo@hsr.it.; Università Vita-Salute San Raffaele, Milan, Italy. corti.angelo@hsr.it.
Publikováno v:
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2024 Jan 30; Vol. 81 (1), pp. 68. Date of Electronic Publication: 2024 Jan 30.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Muñoz-Wolf N; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland; Translational & Respiratory Immunology Lab, Department of Clinical Medicine, School of Medicine, Trinity Biomedical Sciences Institute, Dublin D02 R590, Ireland; Clinical Medicine Tallaght University Hospital, Dublin D24 NR04, Ireland., Ward RW; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland., Hearnden CH; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland., Sharp FA; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland., Geoghegan J; Department of Microbiology, Moyne Institute of Preventive Medicine, School of Genetics and Microbiology, Trinity College Dublin, Dublin, Ireland; Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK., O'Grady K; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland., McEntee CP; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland., Shanahan KA; School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin D02 R590, Ireland., Guy C; School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin D02 R590, Ireland., Bowie AG; School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin D02 R590, Ireland., Campbell M; Smurfit Institute of Genetics, School of Genetics and Microbiology, Trinity College Dublin, Dublin, Ireland., Roces CB; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK., Anderluzzi G; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK., Webb C; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK., Perrie Y; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK., Creagh E; School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin D02 R590, Ireland., Lavelle EC; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland; Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN) & Advanced Materials Bio-Engineering Research Centre (AMBER), Trinity College Dublin, Dublin D02 PN40, Ireland. Electronic address: lavellee@tcd.ie.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2023 Jan 17; Vol. 4 (1), pp. 100899.
Autor:
Corti A; Faculty of Medicine, Università Vita-Salute San Raffaele, 20132 Milan, Italy.; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Anderluzzi G; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Curnis F; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2022 Nov 22; Vol. 14 (12). Date of Electronic Publication: 2022 Nov 22.
The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency.
Autor:
Anderluzzi G; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral St., Glasgow G4 0RE, Scotland, UK; GSK, Siena, Italy., Lou G; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral St., Glasgow G4 0RE, Scotland, UK; GSK, Siena, Italy., Woods S; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral St., Glasgow G4 0RE, Scotland, UK., Schmidt ST; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral St., Glasgow G4 0RE, Scotland, UK; Department of Infectious Disease Immunology, Center for Vaccine Research, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark., Gallorini S; GSK, Siena, Italy., Brazzoli M; GSK, Siena, Italy., Johnson R; GSK, Rockville, MD 9911, USA., Roberts CW; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral St., Glasgow G4 0RE, Scotland, UK., O'Hagan DT; GSK, Rockville, MD 9911, USA., Baudner BC; GSK, Siena, Italy., Perrie Y; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral St., Glasgow G4 0RE, Scotland, UK. Electronic address: yvonne.perrie@strath.ac.uk.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2022 Feb; Vol. 342, pp. 388-399. Date of Electronic Publication: 2021 Dec 10.
Autor:
Sacchi A; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Gasparri AM; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Monieri M; Università Vita-Salute San Raffaele, Milan, Italy., Anderluzzi G; Università Vita-Salute San Raffaele, Milan, Italy., Colombo B; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Gori A; Istituto di Scienze e Tecnologie Chimiche, C.N.R., Milan, Italy., Corti A; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy., Curnis F; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Publikováno v:
Frontiers in chemistry [Front Chem] 2021 May 28; Vol. 9, pp. 690357. Date of Electronic Publication: 2021 May 28 (Print Publication: 2021).
Autor:
Corti A; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, via Olgettina 58, 20132, Milan, Italy. corti.angelo@hsr.it.; Università Vita-Salute San Raffaele, Milan, Italy. corti.angelo@hsr.it., Sacchi A; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, via Olgettina 58, 20132, Milan, Italy., Gasparri AM; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, via Olgettina 58, 20132, Milan, Italy., Monieri M; Università Vita-Salute San Raffaele, Milan, Italy., Anderluzzi G; Università Vita-Salute San Raffaele, Milan, Italy., Colombo B; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, via Olgettina 58, 20132, Milan, Italy., Gori A; Istituto di Scienze e Tecnologie Chimiche, C.N.R., Via Mario Bianco 9, 20131, Milan, Italy., Mondino A; Lymphocyte Activation Unit, Division of Immunology, Transplantation and Infectious Diseases IRCCS San Raffaele Scientific Institute, Milan, Italy., Curnis F; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, via Olgettina 58, 20132, Milan, Italy. curnis.flavio@hsr.it.
Publikováno v:
Journal of nanobiotechnology [J Nanobiotechnology] 2021 May 05; Vol. 19 (1), pp. 128. Date of Electronic Publication: 2021 May 05.
Autor:
Yang, Ruohan1 (AUTHOR), Cui, Jiuwei1 (AUTHOR) cuijw@jlu.edu.cn
Publikováno v:
Molecular Cancer. 10/9/2024, Vol. 23 Issue 1, p1-12. 12p.
Autor:
Lindsay, Sarah1 (AUTHOR) sarah.lindsay@strath.ac.uk, Tumolva, Olympia2 (AUTHOR), Khamiakova, Tatsiana2 (AUTHOR), Coppenolle, Hans2 (AUTHOR), Kovarik, Martin2 (AUTHOR), Shah, Sanket3 (AUTHOR) sshah100@its.jnj.com, Holm, René4 (AUTHOR), Perrie, Yvonne1 (AUTHOR) sshah100@its.jnj.com
Publikováno v:
Pharmaceutics. Sep2024, Vol. 16 Issue 9, p1159. 19p.